28.02.21
Traumatic Brain Injury - Our Another Successful Seminar!
This past Thursday February 25th, Allied Neurology and Interventional Pain Practice hosted another successful seminar. Attendees were invited by Dr. Dariusz Nasiek, Pain Management Specialist and Dr. Ravi Tikoo MD, Board Certified neurologist. A group of doctors, lawyers, chiropractors, and medical technology industry representatives met to discuss Traumatic Brain Injury (TBI) More»

CONTACT

RECOMMENDED

Traumatic Brain Injury - Our Another Successful Seminar!
02.28.2021
Medical Conference of Dr Nasiek at Royal Warsaw Restaurant
01.30.2021
First Dinner Seminar this Year of Dr. Dariusz Nasiek, MD
01.23.2021



BLOG

Traumatic Brain Injury - Our Another Successful Seminar!This past Thursday February 25th, Allied Neurology and Interventional Pain Practice hosted another successful seminar. Attendees were invited by Dr. Dariusz Nasiek, Pain Management Specialist and Dr. Ravi Tikoo MD, Board Certified neurologist. A group of doctors, lawyers, chiropractors, and medical technology industry representatives met to discuss Traumatic Brain Injury (TBI) and new ways of diagnosing this condition and it’s sequelae with Tele EEG.
Medical Conference of Dr Nasiek at Royal Warsaw RestaurantOn Thursday, January 27th, Allied Neurology and Interventional Pain Practice, PC and Dr. Dariusz Nasiek, MD held yet another conference at Royal Warsaw Restaurant. Held in order to accommodate the amount of people who wanted to attend last week’s conference, Dr. Nasiek presented once again on the Medico-Legal Definitions of the Final Diagnoses and Permanency of certain trauma injuries, providing handouts and slides.
First Dinner Seminar this Year of Dr. Dariusz Nasiek, MDOn Thursday, January 21st Allied Neurology and Interventional Pain Practice, PC and Dr. Dariusz Nasiek, MD held its first monthly conference of 2021 at Royal Warsaw Restaurant.
U.S. on Track for Herd Immunity by SummerAs COVID-19 immunization speeds up across the U.S., vaccine makers hope the country will reach mass immunization by the summer and be the first country of its size to meet that goal.
A New Study Suggests Eating Avocados Daily for a 'Happy' GutA new study by researchers at the University of Illinois Urbana-Champaign suggests that people looking to balance their gastrointestinal health may be able to have their avocado toast and eat it, too.The Hass Avocado Board funded the research, but the study authors believe that there is enough evidence to justify making the mildly flavored fruit a regular diet stable.
Op-Ed: Should Those Who Recovered From COVID Take the Vaccine?Right now, the U.S. is entering the next important phase of eradicating COVID-19 -- administering vaccines. There are, of course, critical issues to address, such as how the vaccines will be distributed, which segments of our population should receive vaccination priority, and whether we need to continue wearing masks until herd immunity is achieved.
Study Finds New Evidence of SARS-CoV-2 Damaging Brain Blood VesselsScientists have found no trace of SARS-CoV-2 in the brains of people with the infection. However, they have observed blood vessel damage caused by the body’s inflammatory response in the post-mortem brains of patients who tested positive for the virus, which suggests the virus may indirectly attack the organ. The scientific advances researchers made this past year have helped tremendously in learning about the new coronavirus that first appeared in Wuhan, China.
Half a million fewer women work in healthcare amid pandemic, study findsThe number of healthcare jobs held by women has not yet recovered from the massive losses the industry took in the beginning of the pandemic, a recent study finds.
A New Approach to Study Autoimmune DiseasesA team of researchers led by the Indiana Biosciences Research Institute Diabetes Center's Scientific Director Decio L. Eizirik, MD, Ph.D., has found that identifying new treatments for autoimmune diseases requires studying together the immune system AND target tissues. This study, "Gene expression signatures of target tissues in type 1 diabetes, lupus erythematosus, multiple sclerosis and rheumatoid arthritis," is featured in the Jan. 6, 2021, edition of Science Advances.
pain
aba
microbial
abaz
center